The drugs also seemed to have a reno-protective effect, reducing the composite kidney outcome by 17%
Retatrutide has not been compared head-to-head with earlier GLP-1 medications in any clinical trials, although there is an ongoing trial called TRIUMPH-5, which is comparing it with tirzepatide
High costs, stigma, and limited provider familiarity often stand in the way
Before integrating Semaglutide GLP-1 with any procedure, we conduct thorough evaluations to understand your health status, weight loss goals, and any potential risks or benefits associated with the treatment plan
GLP-1 medications may not always be effective for everyone
identify and engage the patients who use the medications and the providers who prescribed them